GlassScriptPhysician profile
Raghav Mohindra
NPI 1427210426
$16,364.88
in general payments reported to CMS, 2019-2025
76 companies · $907 in 2025
The $907 reported for 2025 was more than what 88% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,618 · 2020: $2,026 · 2021: $3,366 · 2022: $2,277 · 2023: $3,567 · 2024: $604 · 2025: $907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,214 · Travel and Lodging: $1,815 · Entertainment: $47.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,214.40 |
| Travel and Lodging | $1,815.26 |
| Entertainment | $47.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,311.94 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $1,609.35 | 2019-2025 | |
| Modernatx, INC. | $1,372.15 | 2023 | |
| Abbott Laboratories | $983.62 | 2019-2025 | Octrode, Jot Dx, Proclaim |
| Glaxosmithkline, LLC. | $893.96 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $810.08 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $764.62 | 2019-2022 | |
| Pfizer INC. | $652.98 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $515.95 | 2019-2024 | Xarelto |
| Amgen INC. | $480.78 | 2019-2025 | Repatha, Evenity, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $475.39 | 2019-2024 | Jardiance |
| Novo Nordisk INC | $397.29 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amarin Pharma, INC. | $367.64 | 2019-2022 | |
| Watermark Medical, INC. | $309.98 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $278.83 | 2019-2023 |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $263.01 | 2020-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $247.24 | 2019-2023 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $241.70 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $203.56 | 2020-2022 | |
| Endologix LLC | $199.34 | 2019 | |
| Dexcom, INC. | $162.36 | 2021-2022 | |
| Philips North America LLC | $157.96 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $152.49 | 2019-2023 | Belsomra |
| Kowa Pharmaceuticals America, INC. | $146.13 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $141.85 | 2022-2025 | Rexulti, Nuedexta |
| Radius Health, INC. | $141.30 | 2019-2020 | |
| Lilly USA, LLC | $131.42 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Ucb, INC. | $128.05 | 2019-2021 | |
| Allergan, INC. | $123.90 | 2020 | |
| Novartis Pharmaceuticals Corporation | $117.00 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $112.11 | 2019-2023 | Austedo Xr, Austedo |
| Medtronic USA, INC. | $108.80 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.01 | 2021-2022 | |
| Pacira Therapeutics, INC. | $71.83 | 2021 | |
| Medtronic, INC. | $61.79 | 2022-2024 | Intellis Adaptivestim, Minimed 780g |
| Almatica Pharma LLC | $59.20 | 2022 | |
| Organogenesis INC. | $56.08 | 2019-2021 | |
| Lundbeck LLC | $51.77 | 2023-2025 | Rexulti |
| Sumitomo Pharma America, INC. | $50.66 | 2023-2024 | Gemtesa |
| Optos, INC. | $47.78 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Biotronik Nro, INC. | $46.42 | 2024-2025 | Prospera |
| Neurelis, INC. | $44.06 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $43.07 | 2021 | |
| Seqirus USA INC | $42.99 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $38.22 | 2025 | Zenpep |
| Xeris Pharmaceuticals, INC. | $36.23 | 2022-2024 | Recorlev |
| Horizon Therapeutics Plc | $30.14 | 2021 | |
| Paratek Pharmaceuticals, INC. | $29.97 | 2024-2025 | Nuzyra |
| Ge Healthcare | $28.49 | 2019 | |
| Bard Peripheral Vascular, INC. | $27.67 | 2024 | Rotarexs 6 F X 135 Cm |
| Lucid Diagnostics INC. | $26.80 | 2021 | |
| Exact Sciences Corporation | $26.71 | 2024 | Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $26.15 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.50 | 2025 | Lifevest |
| Rgh Enterprises LLC | $24.25 | 2025 | |
| Corium, LLC | $23.34 | 2022-2023 | Adlarity |
| Globus Medical, INC. | $22.96 | 2025 | Senza |
| Smith+Nephew, INC. | $22.75 | 2019 | |
| Nevro Corp. | $22.64 | 2024 | Senza |
| Ibsa Pharma INC. | $22.29 | 2025 | Licart, Flector, Tirosint |
| Axonics, INC. | $22.00 | 2024 | Axonics |
| Biohaven Pharmaceutical Holding Company LTD. | $19.35 | 2022 | |
| Ardelyx, INC. | $18.84 | 2024 | Ibsrela |
| Bardy Diagnostics, INC. | $18.53 | 2022 | |
| Corcept Therapeutics | $17.71 | 2021 | |
| Renalytix Ai, INC. | $17.69 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Ethicon US, LLC | $16.58 | 2021 | |
| Sun Pharmaceutical Industries INC. | $16.50 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.19 | 2022 | |
| Boston Scientific Corporation | $15.64 | 2024 | Watchman Flx |
| Daiichi Sankyo INC. | $15.61 | 2019 | |
| Medtronic Vascular, INC. | $15.40 | 2019 | |
| Alfasigma USA, INC. | $15.11 | 2022 | |
| Neurocrine Biosciences, INC. | $14.93 | 2023 | Ingrezza |
| Baxter Healthcare | $14.49 | 2022 | |
| Insulet Corporation | $13.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raghav Mohindra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.